ISRCTN15318304进行中（未招募）Unknown
Fecal microbiota transplantation for induction of remission in mild to moderate active Crohn’s disease
适应症
试验速览
- 阶段
- Unknown
- 状态
- 进行中（未招募）
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patients with mild to moderate active CD, defined as CDAI 150-449
- •2. Ileal, ileo-colonic or colonic disease location
- •3. Inflammatory (non-penetrating non-stricturing disease behavior)
- •4. Diagnosis (endoscopic or radiographic and histological) of IBD at least 6 months prior to enrolment into the study
- •5. Subjects who are willing and able to comply with treatment plan, laboratory tests
- •6. Subjects who are willing to provide written informed consent
排除标准
- •Patients with severe, penetrating and stricturing, or perianal fistulizing CD
研究者
相似试验
招募中
2 期
A-FMT for active UCMild to moderate ulcerative colitisUlcerative colitisJPRN-jRCTs031220542agahara Akihito37
招募中
2 期
Fecal microbiota transplantation for intractable gastrointestinal diseases(FEMIGI study)1)Clostridium difficile infection 2)Crohn disease, ulcerative colitis 3)Chronic Enteropathy associatJPRN-jRCTs041190021Ohmiya Naoki50
尚未招募
不适用
Fecal microbiota transplantation for eradication of Vancomycin-Resistant EnterococciVancomycin-resistant Enterococci carriageAntibiotic resistanceDragerschap vancomycine-resistente Enterococ Antibiotica resistentieNL-OMON25381niversity Medical Center Utrecht10
撤回
2 期
Fecal Microbiota Transplantation for eradication of Vancomycin-resistant Enterococci (FAVOR): a pilot studyCarriage of vancomycin-resistant Enterococvancomycin-resistant Enterococ carrier10004018NL-OMON46675niversitair Medisch Centrum Utrecht10
招募中
不适用
Fecal Microbiota Transplantation to Restore Residual Beta Cell Function In Patients With Long- Duration Type 1 Diabetes Mellitustype 1 diabetesNL-OMON27205Amsterdam UMC34